SCHEMBL14697294

SCHEMBL14697294

CC(C)(C)C1CC[C](O[SiH](c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
GLA P06280 1/20 0.36
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 4/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GAA P10253 4/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
HPGD P15428 2/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9354704 0.78 CES2 (0.34) NPC1RAB9AGLAALDH1A1TDP1
SCHEMBL9354690 0.78 MAPT (0.41) NPC1RAB9AGLAALDH1A1LMNA
SCHEMBL5337930 0.70 NPC1 (0.36) NPC1RAB9AGLAALDH1A1KDM4E
SCHEMBL5724562 0.69 GLA (0.31) NPC1RAB9AGLAALDH1A1TDP1
SCHEMBL10437849 0.67 GLA (0.40) GLAALDH1A1TDP1KDM4EMAPT
SCHEMBL4113192 0.67 ALDH1A1 (0.40) NPC1RAB9AGLAALDH1A1TDP1
SCHEMBL10437852 0.67 GLA (0.40) GLAALDH1A1TDP1KDM4EMAPT
SCHEMBL7630715 0.66 TDP1 (0.49) GLAALDH1A1TDP1LMNAKDM4E
SCHEMBL7344540 0.65 ALDH1A1 (0.34) GLAALDH1A1TDP1KDM4EMAPT
SCHEMBL7339045 0.65 ALDH1A1 (0.34) GLAALDH1A1TDP1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013025628-A1 JANUS KINASE INHIBITOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2013-02-21 WO disclosed